Critically, in these studies, blockage of IL-6 rescued mice from cancer-associated thrombocytosis, and murine models lacking a hepatic IL-6 receptor did not have elevations in platelet count associated with tumor growth, corroborating the major role IL-6 plays in mediating cancer-related thrombocytosis. The gene discussed is IL6; the disease is Thrombocytosis.